Allscripts, Misys complete $325M merger

After a series of financial roadblocks, Misys Healthcare Systems has finalized its purchase of Allscripts Healthcare Solutions, in a transaction totaling $325 million. The result of the merger is the formation of a new company, Allscripts-Misys Healthcare Solutions (AllscriptsMisys).

The proposed merger, which started back in March, hit a roadblock in September, when Misys’ credit facility Lehman Brothers filed for bankruptcy, forcing the company to seek alternative sources of funding.

In late September, Misys obtained sufficient funding, putting the deal back on track.

The newly integrated company now has a client base of nearly one-third of the practicing physicians in the United States. AllscriptsMisys also provides information and connectivity solutions to more than 700 U.S. hospitals and nearly 7,000 post-acute and homecare organizations, according to Glen Tullman, CEO of AllscriptsMisys.

The brand name of AllscriptsMisys is Allscripts.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.